Joannes Petrus Van Dun

Joannes Petrus Van Dun is a notable inventor based in Lille, Belgium. With a total of two patents to his name, he has made significant contributions to the field of pharmaceutical chemistry. His work primarily focuses on innovative processes related to drug development and synthesis.

Latest Patents

Among his latest patents, Van Dun has developed a resolution process for (±)-methyl phenyl[4-[4-[[[4'-(trifluoromethyl)-2-biphenylyl]carbonyl]amino]phenyl]-1-piperidinyl]acetate. This invention aims to isolate the microsomal triglyceride transfer protein (MTP) inhibitor methyl (2S)-phenyl[4-[4-[[[4'-(trifluoromethyl)-2-biphenylyl]carbonyl]amino]phenyl]-1-piperidinyl]acetate, along with an epimerisation procedure for racemizing methyl (2R)-phenyl[4-[4-[[[4'-(trifluoromethyl)-2-biphenylyl]carbonyl]amino]phenyl]-1-piperidinyl]acetate. Additionally, he has patented a process for preparing crystalline 3-(2-chloro-ethyl)-9-hydroxy-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one, which is substantially free of 2-acetylbutyrolactone.

Career Highlights

Van Dun works at Janssen Pharmaceutica NV, a well-respected company in the pharmaceutical industry. His role as an inventor plays a crucial part in advancing the company's research and development initiatives. His efforts in creating efficient synthesis methods have positioned him as a valuable asset in the quest for new therapeutic solutions.

Collaborations

Throughout his career, Joannes Petrus Van Dun has collaborated with esteemed colleagues, including Alex Herman Copmans and Jérôme Albert Joseph Hoet. Their combined expertise has propelled various projects forward, contributing to successfully patented innovations.

Conclusion

Joannes Petrus Van Dun stands out as an influential figure in pharmaceutical innovation. Through his innovative patents and collaborations with fellow researchers, he continues to shape the landscape of drug development, paving the way for future medical advancements.

Profile summary based on public USPTO records.